A First Look at the Numbers A 2026 study published in The Lancet Obstetrics, Gynaecology, and Women's Health took a direct look at this question, evaluating 120 postmenopausal women treated with tirzepatide, one of the most effective GLP-1 and GIP dual receptor agonists currently available [16]
Viking Therapeutics, Zealand-linked assets, and emerging oral obesity platforms remain important areas to monitor
Nitric Oxide System Interaction: The peptide interacts with the nitric oxide system, which regulates blood vessel dilation and blood flow
This passive dissolution is gentler on the peptide than immediate agitation
For individuals focused exclusively on type 2 diabetes management, Ozempic may be the preferred option due to its proven efficacy in enhancing glycemic control
This surge coincided with Zepbounds approval for OSA, marking the largest observed difference in uptake between patients with and without a comorbidity